Summary

The global Animal Biological Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 559%.
LP Information, Inc. (LPI) ' newest research report, the “Animal Biological Vaccine Industry Forecast” looks at past sales and reviews total world Animal Biological Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Biological Vaccine sales for 2025 through 2031. With Animal Biological Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Biological Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Animal Biological Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal Biological Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Biological Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Biological Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Biological Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal Biological Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Oral
Subcutaneous
Intramuscular
Others
Segmentation by Application:
Porcine
Poultry
Livestock
Companion Animals
Aquaculture
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Merck
Zoetis
Merial/Sanofi
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco/Eli Lilly
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken
FATRO
Vaksindo
Bio-Labs
Avimex Animal
Key Questions Addressed in this Report
What is the 10-year outlook for the global Animal Biological Vaccine market?
What factors are driving Animal Biological Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal Biological Vaccine market opportunities vary by end market size?
How does Animal Biological Vaccine break out by Type, by Application?

ページTOPに戻る

List of Tables/Graphs

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Animal Biological Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Animal Biological Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Animal Biological Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Animal Biological Vaccine Segment by Type
2.2.1 Oral
2.2.2 Subcutaneous
2.2.3 Intramuscular
2.2.4 Others
2.3 Animal Biological Vaccine Sales by Type
2.3.1 Global Animal Biological Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Animal Biological Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Animal Biological Vaccine Sale Price by Type (2020-2025)
2.4 Animal Biological Vaccine Segment by Application
2.4.1 Porcine
2.4.2 Poultry
2.4.3 Livestock
2.4.4 Companion Animals
2.4.5 Aquaculture
2.5 Animal Biological Vaccine Sales by Application
2.5.1 Global Animal Biological Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Animal Biological Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Animal Biological Vaccine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Animal Biological Vaccine Breakdown Data by Company
3.1.1 Global Animal Biological Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Animal Biological Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Animal Biological Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Animal Biological Vaccine Revenue by Company (2020-2025)
3.2.2 Global Animal Biological Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Animal Biological Vaccine Sale Price by Company
3.4 Key Manufacturers Animal Biological Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal Biological Vaccine Product Location Distribution
3.4.2 Players Animal Biological Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Animal Biological Vaccine by Geographic Region
4.1 World Historic Animal Biological Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Animal Biological Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Animal Biological Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Animal Biological Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Animal Biological Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Animal Biological Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Animal Biological Vaccine Sales Growth
4.4 APAC Animal Biological Vaccine Sales Growth
4.5 Europe Animal Biological Vaccine Sales Growth
4.6 Middle East & Africa Animal Biological Vaccine Sales Growth
5 Americas
5.1 Americas Animal Biological Vaccine Sales by Country
5.1.1 Americas Animal Biological Vaccine Sales by Country (2020-2025)
5.1.2 Americas Animal Biological Vaccine Revenue by Country (2020-2025)
5.2 Americas Animal Biological Vaccine Sales by Type (2020-2025)
5.3 Americas Animal Biological Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal Biological Vaccine Sales by Region
6.1.1 APAC Animal Biological Vaccine Sales by Region (2020-2025)
6.1.2 APAC Animal Biological Vaccine Revenue by Region (2020-2025)
6.2 APAC Animal Biological Vaccine Sales by Type (2020-2025)
6.3 APAC Animal Biological Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Animal Biological Vaccine by Country
7.1.1 Europe Animal Biological Vaccine Sales by Country (2020-2025)
7.1.2 Europe Animal Biological Vaccine Revenue by Country (2020-2025)
7.2 Europe Animal Biological Vaccine Sales by Type (2020-2025)
7.3 Europe Animal Biological Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Animal Biological Vaccine by Country
8.1.1 Middle East & Africa Animal Biological Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Animal Biological Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Animal Biological Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Animal Biological Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal Biological Vaccine
10.3 Manufacturing Process Analysis of Animal Biological Vaccine
10.4 Industry Chain Structure of Animal Biological Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal Biological Vaccine Distributors
11.3 Animal Biological Vaccine Customer
12 World Forecast Review for Animal Biological Vaccine by Geographic Region
12.1 Global Animal Biological Vaccine Market Size Forecast by Region
12.1.1 Global Animal Biological Vaccine Forecast by Region (2026-2031)
12.1.2 Global Animal Biological Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Animal Biological Vaccine Forecast by Type (2026-2031)
12.7 Global Animal Biological Vaccine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Animal Biological Vaccine Product Portfolios and Specifications
13.1.3 Merck Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Zoetis
13.2.1 Zoetis Company Information
13.2.2 Zoetis Animal Biological Vaccine Product Portfolios and Specifications
13.2.3 Zoetis Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Zoetis Main Business Overview
13.2.5 Zoetis Latest Developments
13.3 Merial/Sanofi
13.3.1 Merial/Sanofi Company Information
13.3.2 Merial/Sanofi Animal Biological Vaccine Product Portfolios and Specifications
13.3.3 Merial/Sanofi Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merial/Sanofi Main Business Overview
13.3.5 Merial/Sanofi Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Animal Biological Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Ceva
13.5.1 Ceva Company Information
13.5.2 Ceva Animal Biological Vaccine Product Portfolios and Specifications
13.5.3 Ceva Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ceva Main Business Overview
13.5.5 Ceva Latest Developments
13.6 CAHIC
13.6.1 CAHIC Company Information
13.6.2 CAHIC Animal Biological Vaccine Product Portfolios and Specifications
13.6.3 CAHIC Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CAHIC Main Business Overview
13.6.5 CAHIC Latest Developments
13.7 HVRI
13.7.1 HVRI Company Information
13.7.2 HVRI Animal Biological Vaccine Product Portfolios and Specifications
13.7.3 HVRI Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 HVRI Main Business Overview
13.7.5 HVRI Latest Developments
13.8 Ringpu Biology
13.8.1 Ringpu Biology Company Information
13.8.2 Ringpu Biology Animal Biological Vaccine Product Portfolios and Specifications
13.8.3 Ringpu Biology Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ringpu Biology Main Business Overview
13.8.5 Ringpu Biology Latest Developments
13.9 Yebio
13.9.1 Yebio Company Information
13.9.2 Yebio Animal Biological Vaccine Product Portfolios and Specifications
13.9.3 Yebio Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Yebio Main Business Overview
13.9.5 Yebio Latest Developments
13.10 DHN
13.10.1 DHN Company Information
13.10.2 DHN Animal Biological Vaccine Product Portfolios and Specifications
13.10.3 DHN Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 DHN Main Business Overview
13.10.5 DHN Latest Developments
13.11 WINSUN
13.11.1 WINSUN Company Information
13.11.2 WINSUN Animal Biological Vaccine Product Portfolios and Specifications
13.11.3 WINSUN Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 WINSUN Main Business Overview
13.11.5 WINSUN Latest Developments
13.12 Elanco/Eli Lilly
13.12.1 Elanco/Eli Lilly Company Information
13.12.2 Elanco/Eli Lilly Animal Biological Vaccine Product Portfolios and Specifications
13.12.3 Elanco/Eli Lilly Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Elanco/Eli Lilly Main Business Overview
13.12.5 Elanco/Eli Lilly Latest Developments
13.13 Virbac
13.13.1 Virbac Company Information
13.13.2 Virbac Animal Biological Vaccine Product Portfolios and Specifications
13.13.3 Virbac Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Virbac Main Business Overview
13.13.5 Virbac Latest Developments
13.14 Jinyu Bio-Technology
13.14.1 Jinyu Bio-Technology Company Information
13.14.2 Jinyu Bio-Technology Animal Biological Vaccine Product Portfolios and Specifications
13.14.3 Jinyu Bio-Technology Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jinyu Bio-Technology Main Business Overview
13.14.5 Jinyu Bio-Technology Latest Developments
13.15 ChengDu Tecbond
13.15.1 ChengDu Tecbond Company Information
13.15.2 ChengDu Tecbond Animal Biological Vaccine Product Portfolios and Specifications
13.15.3 ChengDu Tecbond Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 ChengDu Tecbond Main Business Overview
13.15.5 ChengDu Tecbond Latest Developments
13.16 CAVAC
13.16.1 CAVAC Company Information
13.16.2 CAVAC Animal Biological Vaccine Product Portfolios and Specifications
13.16.3 CAVAC Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 CAVAC Main Business Overview
13.16.5 CAVAC Latest Developments
13.17 Kyoto Biken
13.17.1 Kyoto Biken Company Information
13.17.2 Kyoto Biken Animal Biological Vaccine Product Portfolios and Specifications
13.17.3 Kyoto Biken Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Kyoto Biken Main Business Overview
13.17.5 Kyoto Biken Latest Developments
13.18 FATRO
13.18.1 FATRO Company Information
13.18.2 FATRO Animal Biological Vaccine Product Portfolios and Specifications
13.18.3 FATRO Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 FATRO Main Business Overview
13.18.5 FATRO Latest Developments
13.19 Vaksindo
13.19.1 Vaksindo Company Information
13.19.2 Vaksindo Animal Biological Vaccine Product Portfolios and Specifications
13.19.3 Vaksindo Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Vaksindo Main Business Overview
13.19.5 Vaksindo Latest Developments
13.20 Bio-Labs
13.20.1 Bio-Labs Company Information
13.20.2 Bio-Labs Animal Biological Vaccine Product Portfolios and Specifications
13.20.3 Bio-Labs Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Bio-Labs Main Business Overview
13.20.5 Bio-Labs Latest Developments
13.21 Avimex Animal
13.21.1 Avimex Animal Company Information
13.21.2 Avimex Animal Animal Biological Vaccine Product Portfolios and Specifications
13.21.3 Avimex Animal Animal Biological Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 Avimex Animal Main Business Overview
13.21.5 Avimex Animal Latest Developments
14 Research Findings and Conclusion